<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03201055</url>
  </required_header>
  <id_info>
    <org_study_id>MA100517</org_study_id>
    <nct_id>NCT03201055</nct_id>
  </id_info>
  <brief_title>Snore Positive Airway Pressure Trial</brief_title>
  <official_title>Assessment of Performance, Usability and Acceptance of a Continuous Positive Airway Pressure System to Alleviate Self-reported Snore in Non-apnoeic Participants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eden Sleep</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will aim to assess the acceptance of the Snore PAP system as a treatment concept&#xD;
      for snore. The study will subjectively assess participant and bed partner acceptability and&#xD;
      usability of the Snore PAP system and objectively assess participant compliance with the&#xD;
      Snore PAP system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2, 2017</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjectively assess the participant and bed partner acceptability and usability of Snore PAP system</measure>
    <time_frame>28 Nights</time_frame>
    <description>Subjective assessment will be assessed using the Likert scale using a 0-10 scale. With 0 being very negative and 10 being very positive.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjectively assess the performance of the Snore PAP system in relieving: self-reported and bed partner reported snore in non-apnoeic participants.</measure>
    <time_frame>28 Nights</time_frame>
    <description>Subjective assessment will be assessed using the Likert scale using a 0-10 scale. With 0 being very negative and 10 being very positive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objectively assess participant compliance with the Snore PAP system</measure>
    <time_frame>28 Nights</time_frame>
    <description>Hours used per night</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Non-Apnoeic Snorers</condition>
  <arm_group>
    <arm_group_label>Non Apnoeic Snorers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient's use the Snore Positive airway pressure device for 28 nights.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Snore PAP System</intervention_name>
    <description>The Snore PAP system delivers a set Continuous Positive Airway Pressure (CPAP) and consists of a CPAP flow generator and an approved pillows mask.The system will deliver a fixed positive airflow to the participant via approved tubing and pillows mask.</description>
    <arm_group_label>Non Apnoeic Snorers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Participants willing to provide written informed consent&#xD;
&#xD;
          -  Participants who can read and comprehend written and spoken English&#xD;
&#xD;
          -  Participants who are ≥ 18 years of age&#xD;
&#xD;
          -  Participants are CPAP naïve&#xD;
&#xD;
          -  Participants who are self/ partner reported snorers&#xD;
&#xD;
          -  Participants whose ApneaLink study results demonstrate snore&#xD;
&#xD;
          -  Participants who are willing to use Nice system in place of current non prescribed&#xD;
             methods for alleviating snore&#xD;
&#xD;
          -  Participants have a bed partner&#xD;
&#xD;
          -  Participant's bed partner willing to answer assessment questionnaire&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Participants previously diagnosed with obstructive or central sleep apnoea&#xD;
&#xD;
          -  Participants whose ApneaLink home study indicates AHI ≥6&#xD;
&#xD;
          -  Participants who are pregnant or breastfeeding&#xD;
&#xD;
          -  Participants who have a pre-existing lung disease/ condition that would predispose&#xD;
             them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (&lt;&#xD;
             2years) case of pneumonia or lung infection; lung injury)&#xD;
&#xD;
          -  Participants with severe bullous lung disease, history of pneumothorax, pathologically&#xD;
             low blood pressure, dehydration, cerebrospinal fluid leak, recent cranial surgery or&#xD;
             trauma.&#xD;
&#xD;
          -  Participants who cannot participate for the duration of the trial&#xD;
&#xD;
          -  Participants who are established on bi-level support therapy&#xD;
&#xD;
          -  Participants currently using a prescribed medication/ device to alleviate snore&#xD;
&#xD;
          -  Participants who are physically unable to comply with the protocol- no access to&#xD;
             internet to conduct online visits with researcher or unable to attend clinic for visit&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>EdenSleep</name>
      <address>
        <city>New Plymouth</city>
        <zip>4312</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>June 22, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2017</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

